DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "MediPoint: Spinal Fusion - Global Analysis and Market Forecasts" report to their offering.
Global market for spinal fusion, which includes spinal plating systems, interbody devices, vertebral body replacement devices, and pedicle screw systems (excluding minimally invasive spine devices), is set to rise from approximately $7.1 Billion in 2016 to just under $9 Billion by 2023, representing a compound annual growth rate of 3.4%.
This states that relatively steady market growth, which covers 39 countries, will primarily be driven by the growing prevalence of degenerative spinal conditions due to aging, continued technological advancements in spinal fusion surgeries, such as expendable interbody cages and navigation systems, and the increased adoption of minimally invasive techniques.
Spinal fusion surgery is a well-established procedure that has been performed since the early 1900s. The procedure has benefited immensely from its long history of use, investments in advancing technologies, and its clinical success in a growing variety of spinal conditions. These traits have led spinal fusion surgery to become one of the most frequently performed surgeries in the US, which is undoubtedly, the largest geographic market for this procedure.
The US healthcare system has grown wary of the extensive growth of spinal fusion procedures, as data emerge indicating the number of medically unnecessary surgeries that are being performed. Medicare estimates that more than $200 Million was spent on improperly indicated spinal fusion procedures in 2011.
Key Topics Covered:
3 Industry Overview
4 Unmet Needs and Market Opportunity Analysis
4.1 Lack of Definitive Methods to Determine Fusion Performance
4.2 Technological Developments in the Use of Long Fusions
4.3 Research and Development into Fusion Enhancers
4.4 Develop Signature Minimally Invasive Technique
4.5 Develop a Device that Provides Real-Time Fusion Updates
5 Market Drivers and Barriers
5.1 Driver: Gold Standard for Treating Spinal Instability and Degenerative Conditions
5.2 Driver: Growth in the Spinal Stenosis Indication
5.3 Driver: Expandable Spinal Implants
5.4 Driver: Treatment for a Variety of Indications
5.5 Driver: Advances in Navigation Technology
5.6 Barrier: Incidence of Adjacent Segment Disease
5.7 Barrier: Increased Scrutiny over Spinal Fusion's Necessity in the US
5.8 Barrier: Restricted Reimbursement from Private Payers
5.9 Barrier: Performance in Treating Axial Back Pain
6 Competitive Assessment
6.1 Company Market Share
6.2 Company Profiles
6.2.2 Alphatec Spine
6.2.3 Amedica Corporation
6.2.4 DePuy Synthes
6.2.5 Globus Medical
6.2.12 Zimmer Biomet
6.3 Pipeline Assessment
7 Market Outlook
7.1 Procedure Trends
7.2 By Geography
For more information about this report visit http://www.researchandmarkets.com/research/dhd9r3/medipoint_spinal